Unilever Research confirms the Efficacy of CPC Technology in Oralcare Formulations against COVID-19
Unilever has confirmed that preliminary lab test results show that a mouthwash formulation containing CPC Technology, reduces 99.9% of SARS-CoV-2, the virus that causes COVID-19, after 30 seconds of rinsing. The preliminary test results on SARS-CoV-2 build on existing Unilever research published on the biology research platform bioRxiv and follow ongoing discussions in the global medical and scientific community around the potential use of mouthwash as an additional measure to reduce the transmission of the virus. Research into the duration of the effect continues, but a previous study on a small group of patients infected with COVID-19 suggest that viral load – the number of virus particles a person is carrying – may be reduced in the mouth for up to six hours by using mouthwashes containing CPC.
These preliminary test results, showing the efficacy of CPC Technology against the SARS-CoV-2 virus, are the latest in a large range of studies that are evaluating the efficacy of mouthwash technology against a number of viruses.
Subscribe to our free newsletter to read the latest news and articles before they are published.